Another study suggested that down-regulation of BGN levels in models such as unilateral ureteral obstruction and lupus nephritis effectively reduces the expression levels of nucleotide-binding oligomerisation domain-like receptor protein 3 (NLRP3) and caspase-1 activity. The gene discussed is BGN; the disease is lupus nephritis.